A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans
Matilu Mwau(MRC Human Immunology Unit), Tomáš Hanke(University of Oxford), Nicola Winstone(MRC Human Immunology Unit), Inese Cebere(MRC Human Immunology Unit), Sarah Rowland‐Jones(University of Oxford), P. Chikoti(MRC Human Immunology Unit), Lucy Dorrell(MRC Human Immunology Unit), Andrew J. McMichael(Nuffield Orthopaedic Centre), Sandip Pravin Patel(University of California San Diego), Helen McShane(University of Oxford), Tara Beattie(London School of Hygiene & Tropical Medicine), Christopher P. Conlon(Oxford Health NHS Foundation Trust), Claudia Schmidt(German Cancer Research Center), Joanna Roberts(MRC Human Immunology Unit), Julian Sutton(MRC Human Immunology Unit), Edmund G. Wee(MRC Human Immunology Unit), Yun‐Hsiang Chen(University of St Andrews), Job J. Bwayo(University of Nairobi), Mary Brooks(MRC Human Immunology Unit)
Cited by 210
Related Papers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
|Nature Medicine|1997|1.1k